Last reviewed · How we verify
NCT06379672
Resonance Breathing Training for Long Covid-related Myocardial Injury
NA trial testing Resonance breathing in Long COVID in 70 participants. Not yet recruiting.
25 September 2024
Quick facts
| Lead sponsor | Chengdu Sport University |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 70 |
| Start date | 25 August 2024 |
| Primary completion | 25 September 2024 |
| Estimated completion | 5 October 2024 |
Drugs / interventions tested
- Resonance breathing
Conditions studied
- Long COVID — all drugs for Long COVID →
- Myocardial Injury — all drugs for Myocardial Injury →
Sponsor
Chengdu Sport University
Who can join
Adults 18 to 60, any sex, with Long COVID or Myocardial Injury. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
An investigation of the efficacy of resonance breathing training in the rehabilitation of patients with Long covid-related myocardial injury
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06379672
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Resonance breathing
Trials testing the same drug.
- NCT05369169 — Afferent Neurocardiac Signals, Cue Reactivity, and Cognitive Control · NA · unknown
Other recruiting trials for Long COVID
Currently open trials in the same condition.
- NCT05931497 — Sauna for Long Covid · NA · recruiting
- NCT06452095 — Recovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine Trial - Effect of Hyperbaric Oxygen Therapy fo · NA · recruiting
- NCT07316127 — Immunoadsorption in Autoimmune Long COVID · Phase 2 · recruiting
- NCT07435805 — Long-Term Health Effects of Previous COVID-19 in Patients Undergoing Preoperative Anesthesia Evaluation · recruiting
- NCT07278206 — Brain Stimulation in Long COVID · NA · recruiting
Other Chengdu Sport University trials
Trials by the same sponsor.
- NCT06870656 — Muscle Isometric Contraction for the Treatment of Knee Osteoarthritis · NA · not yet recruiting
- NCT06921096 — Cessation on Internet Addiction in College Students · NA · not yet recruiting
- NCT06760468 — Development and Evaluation of Functional Probiotic Powder in Human Trials · NA · not yet recruiting
- NCT06535321 — Delayed Onset Muscle Soreness of Athletes · NA · not yet recruiting
- NCT06553963 — Athlete Biochemical Monitoring and Nutritional Support · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06379672 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Chengdu Sport University
- Last refreshed: 30 July 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06379672.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing